Achieve Life Sciences Grants Awards to Three New Hires
The company granted stock options and RSU awards covering 97,000 shares each as inducement grants for newly hired employees.
Updated on Nov. 2, 2026 in Public Companies
Achieve Life Sciences granted stock options and restricted stock unit awards, each covering 97,000 shares of common stock, to three new employees. The awards were approved by the company's Compensation Committee and made under its 2024 Equity Inducement Plan.
Why it matters
The inducement grants are a standard tool used to attract new employees to the late-stage specialty pharmaceutical company, which is developing cytisinicline as a treatment for nicotine dependence. The awards tie employee compensation to the company's stock price and to continued service over a four-year vesting period.
The company granted 97,000 stock option shares and 97,000 RSU shares across three new hires, with options vesting 25% at the first anniversary and the remaining 75% over 36 equal monthly installments. The filing does not state the grant-date share price or the total value of the awards.
The players
Achieve Life Sciences
Achieve Life Sciences is a late-stage specialty pharmaceutical company developing cytisinicline, an investigational compound that binds to nicotinic receptors, as a treatment for nicotine dependence.
The details
The Compensation Committee approved the grants, which were made as an inducement to entering employment and in accordance with Nasdaq Listing Rule 5635(c)(4). Each RSU represents the right to receive one common share upon vesting, and the awards remain subject to the terms of the 2024 Equity Inducement Plan.
Timeline
November 2, 2026: Achieve Life Sciences announced the new hire inducement award grants.
Market Landscape
Nasdaq Listing Rule 5635(c)(4) lets listed companies issue equity to new employees as an inducement without a shareholder vote, a common practice among Nasdaq-listed biotechnology firms competing for scarce talent. Achieve's grants follow that established pattern rather than departing from it.
For shareholders, the grants add 194,000 potential shares to the company's equity pool, which can dilute existing ownership if the awards vest and are exercised. Employees receiving the awards gain a stake in the company's share price, with value depending on whether the stock rises above the grant-date price.
The takeaway
Equity inducement grants are a routine way for small public biotechs to recruit talent, and their value to recipients rises or falls with the stock price after the grant date. Readers following the company can track future filings for exercise activity and share count changes.
Further reading
For more on how listed firms structure equity pay, see Public Companies coverage.
Source note: This article includes information reported by The Manila times.
